A current global view of environmental and occupational cancers

Journal of Environmental Science and Health - Part C Environmental Carcinogenesis and Ecotoxicology Reviews

Volumn 29, Issue 3, 2011, Pages 223-249

  Yang, Mihi ^a  

^a Sookmyung Women's University   (South Korea)

Author keywords

biomarkers; cancers; environment; exposure; occupation; omics; prevention

Indexed keywords

CANCERS; ENVIRONMENT; EXPOSURE; OCCUPATION; OMICS; PREVENTION;

ACCIDENT PREVENTION; AMINES; AROMATIC COMPOUNDS; ARSENIC; BENZENE; BIOMARKERS; CARCINOGENS; CHLORINE COMPOUNDS; CHROMIUM; CLIMATE CHANGE; DEVELOPING COUNTRIES; ELECTROMAGNETIC WAVES; ELECTROMAGNETISM; GENES; HEAVY METALS; HYDROCARBONS; ORGANIC POLLUTANTS; ORGANIC SOLVENTS; RUBBER; RUBBER APPLICATIONS; TEXTILE PROCESSING;

DISEASES;

2',3 DIMETHYL 4 BIPHENYLAMINE; AROMATIC AMINE; ARSENIC; ASBESTOS; BENZENE; BENZIDINE; BENZO[A]PYRENE; BIOLOGICAL MARKER; CARCINOGEN; CHROMIUM; FORMALDEHYDE; NANOMATERIAL; NICKEL; POLYCYCLIC AROMATIC HYDROCARBON; RADON; SILICON DIOXIDE; VINYL CHLORIDE;

BIOLOGICAL MONITORING; BLADDER CANCER; CARCINOGENESIS; CARCINOGENICITY; CLIMATE; DEVELOPING COUNTRY; ELECTROMAGNETIC FIELD; ENVIRONMENTAL FACTOR; FOLLOW UP; HUMAN; LEUKEMIA; LUNG CANCER; MESOTHELIOMA; MINING; OCCUPATIONAL CANCER; PAINTING; POLLUTION; RADIATION; REVIEW; SAFETY; SKIN CANCER; SMOKING; SOOT; TEXTILE; WOOD DUST;

BIOLOGICAL MARKERS; CARCINOGENS, ENVIRONMENTAL; ENVIRONMENTAL MONITORING; HUMANS; NEOPLASMS; OCCUPATIONAL EXPOSURE;

NICOTIANA TABACUM;

EID: 80053105915     PISSN: 10590501     EISSN: 15324095     Source Type: Journal    
DOI: 10.1080/10590501.2011.601848     Document Type: Review

References (114)

1. Boyle P, Bernard L, eds. World cancer report. Lyon, France: IARC/WHO; 2008.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
3. Eckhouse S, Lewison G, Sullivan R. Trends in the global funding and activity of cancer research. Mol Oncol. 2008;2(1):20-32.
4. Jong Y, Park TZ, Tockman MS. Chapter IV. Women's susceptibility to risk and survival from lung cancer. In: Torres VN, ed. Lung cancer in women. Hauppauge, NY: Nova Publishers; 2007:95-113.
5. Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005;366(9499):1784-1793. (Pubitemid 41642642)
6. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981;66(6):1191-1308. (Pubitemid 11063920)
7. IARC/WHO. GLOBOCAN. 2008. http://globocaniarcfr/factsheets/populations. Accessed 2011.
8. Takala J, Schneidar E. Prevention and occupational cancer - the agency's activities. 2008. http://www.nm.stir.ac.uk/documents/jukka-takala-presentation- 25-04-08.pdf, Accessed 2011.
9. Doll R. Epidemiological evidence of the effects of behaviour and the environment on the risk of human cancer. Recent Results Cancer Res. 1998;154:3-21.
10. Roushdy-Hammady I, Siegel J, Emri S, Testa JR, Carbone M. Geneticsusceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet. 2001;357(9254):444-445. (Pubitemid 32156148)
11. Smith AH, Lingas EO, Rahman M. Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bull World Health Organ. 2000;78(9):1093-1103.
12. Julian Eckl RW. North-South? Pitfalls of dividing the world by words. Third World Quarterly. 2007;28(1):3-23.
13. Nelson DI, Concha-Barrientos M, Driscoll T, Steenland K, Fingerhut M, Punnett L, et al. The global burden of selected occupational diseases and injury risks: methodology and summary. Am J Ind Med. 2005; 48(6):400-418. (Pubitemid 41746859)
14. Straif K. The burden of occupational cancer. Occup Environ Med. 2008;65(12):787-788.
15. WHO. Cancer prevention. http://www.whoint/cancer/prevention/en. Accessed 2011.
16. Pukkala E, Martinsen JI, Lynge E, Gunnarsdottir HK, Sparen P, Tryggvadottir L, et al. Occupation and cancer-follow-up of 15 million people in five Nordic countries. Acta Oncol. 2009;48(5):646-790.
17. WHO. Indoor air pollution and health, Fact sheet No292. 2005, http://www.who. int/mediacentre/factsheets/fs292/en, Accessed 2011.
18. Yang M, Pyo MY. Molecular epidemiology of lung cancer in female passive smokers. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2005;23(1):75-97. (Pubitemid 40524494)
19. NIOSH. Genetics in the workplace implications for occupational safety and health. http://www.cdc.gov/niosh/docs/2010-101/pdfs/2010-101.pdf, Accessed 2011.
20. Harding F. Breast cancer a cure at last! Cause-prevention-cure. Bucks, UK: Tekline Publishing; 2006.
21. Boffetta P, Kogevinas M. Occupational cancer in Europe. Environ Health Perspect. 1999;107 (Suppl 2):227.
22. Hayes AW. Principles and methods of toxicology, New York: Informa Healthcare; 2008.
23. Schulte P, Howard J. Genetic susceptibility and the setting of occupational health standards. Annu Rev Public Health. 2011;32:149-159.
24. Hansson SO. Should we protect the most sensitive people? J Radiol Prot. 2009;29(2):211-218.
25. Nebert DW, Roe AL, Vandale SE, Bingham E, Oakley GG. NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review. Genet Med. 2002;4(2):62-70. (Pubitemid 44698580)
26. Kim YJ, Choi JY, Paek D, Chung HW. Association of the NQO1, MPO, and XRCC1 polymorphisms and chromosome damage among workers at a petroleum refinery. J Toxicol Environ Health A. 2008;71(5):333-341. (Pubitemid 351159973)
27. Dinkova-Kostova AT, Talalay P. NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch Biochem Biophys. 2010;501(1):116-123.
28. Okazaki I, Sugita M, Matsuki H, Billah SM, Watanabe T. Additional candidates to conventional genes susceptible for lung cancer and changing trend in Japan. Oncol Rep, 2010;23(6):1493-1500.
29. Janssen GS, Schettler T. Chemical contaminants and human disease, a summary of evidence. http://www.guamagentorange.info/yahoo site admin/assets/docs/CHE Toxicants and Disease Database.160121218.pdf, Accessed 2011.
30. Williams JH, Phillips TD, Jolly PE, Stiles JK, Jolly CM, Aggarwal D. Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions. Am J Clin Nutr. 2004;80(5):1106-1122. (Pubitemid 41350669)
31. North Dakota Department of Health. Erionite. http://www.ndhealth.gov/EHS/ erionite/General/Erionite Fact Sheet.pdf, Accessed 2011.
32. Occupational Safety and Health Administration. Formaldehyde OSHA fact sheet. http://www.osha.gov/OshDoc/data.General.Facts/formaldehyde-factsheet.pdf, Accessed 2011.
33. Weisel CP, Zhang J, Turpin BJ, Morandi MT, Colome S, Stock TH, et al. Relationships of indoor, outdoor, and personal air (RIOPA). Part I. Collection methods and descriptive analyses. Research Report (Health Effects Institute). 2005 Nov;130 (Pt 1):1-107,109-127.
34. Centers for Disease Control and Prevention. Formaldehyde exposure in homes: a reference for state officials to use in decision-making. 2008. http://www.cdc.gov/nceh/ehhe/trailerstudy/pdfs/08 118152 Compendium%20for%20States.pdf, Accessed 2011.
35. Wolkoff P, Nielsen GD. Non-cancer effects of formaldehyde and relevance for setting an indoor air guideline. Environ Int. 2010;36(7):788-799.
36. Maher B. Epidemiology: fear in the dust. Nature. 2010;16;468(7326):884- 885.
37. Park EK, Hannaford-Turner KM, Hyland RA, Johnson AR, Yates DH. Asbestosrelated occupational lung diseases in NSW, Australia and potential exposure of the general population. Ind Health. 2008;46(6):535-540.
38. Gustavsson P, Nyberg F, Pershagen G, Scheele P, Jakobsson R, Plato N. Lowdose exposure to asbestos and lung cancer: dose-response relations and interaction with smoking in a population-based case-referent study in Stockholm, Sweden. Am J Epidemiol. 2002;155(11):1016-1022. (Pubitemid 34587485)
39. Agency for Toxic Substances and Disease Registry. Cigarette smoking, asbestos exposure, and your health. 2006. http://www.atsdr.cdc.gov/asbestos/ site-kit/docs/cigarettesasbestos2.pdf, Accessed 2011.
40. Burki T. Health experts concerned over India's asbestos industry. Lancet. 2010;375(9715):626-627.
41. Park J, Hisanaga N, Kim Y. Transfer of occupational health problems from a developed to a developing country: lessons from the Japan-South Korea experience. Am J IndMed. 2009;52(8):625-632.
42. US Health and Human Services. Toxicological profile for benzene. 2007. http://www.atsdr.cdc.gov/ToxProfiles/tp3.pdf, Accessed 2011.
43. Galbraith D, Gross SA, Paustenbach D. Benzene and human health: a historical review and appraisal of associations with various diseases. Crit Rev Toxicol. 2010;40 Suppl 2:1-46.
44. Infante PF. Benzene: an historical perspective on the American and European occupational setting. Late lessons from early warning: the precautionary principle 1896-2000. Copenhagen, Denmark: European Environmental Agency; 2002:38-51.
45. United Nations Environment Programme. Sound and sustainable management of chemicals. 2008. http://www.sustainlabour.org/IMG/pdf/chem.en.pdf, Accessed 2011.
46. Agency for Toxic Substances and Disease Registry. CERCLA priority list of hazardous substances. 2007. www.atsdr.cdc.gov/cercla/07list.html, Accessed 2011.
47. Lazarus AA, Philip A. Asbestosis. Dis Mon. 2011;57(1):14-26.
48. Donaldson K, Poland CA. Nanotoxicology: new insights into nanotubes. Nat Nanotechnol. 2009;4(11):708-710.
49. Ryman-Rasmussen JP, Cesta MF, Brody AR, Shipley-Phillips JK, Everitt JI, Tewksbury EW, et al. Inhaled carbon nanotubes reach the subpleural tissue in mice. Nat Nanotechnol. 2009;4(11):747-751.
50. Ryman-Rasmussen JP, Tewksbury EW, Moss OR, Cesta MF, Wong BA, Bonner JC. Inhaled multiwalled carbon nanotubes potentiate airway fibrosis in murine allergic asthma. Am J Respir Cell Mol Biol. 2009;40(3):349-358.
51. Nagai H, Toyokuni S. Biopersistent fiber-induced inflammation and carcinogenesis: lessons learned from asbestos toward safety of fibrous nanomaterials. Arch Biochem Biophys. 2010;502(1):1-7.
52. US Food and Drug Administration. Radiation-emitting products: reducing exposure: hands-free kits and other accessories. http://www.fda.gov/Radiation- EmittingProducts/RadiationEmittingProductsandProcedures/ HomeBusinessandEntertainment/CellPhones/ucm116293.htm, Accessed 2011.
53. The Interphone study group. Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study. Int J Epidemiol. 2010;39(3):675-694.
54. National Cancer Institute. Cell phones and cancer risk. http://www.cancer.gov/cancertopics/factsheet/Risk/cellphones, Accessed 2011.
55. Peng RD, Bobb JF, Tebaldi C, McDaniel L, Bell ML, Dominici F. Toward a quantitative estimate of future heat wave mortality under global climate change. Environ Health Perspect. 2011;119(5):701-706.
56. Environmental Health Perspectives and the National Institute of Environmental Health Sciences. A Human Health Perspective on Climate Change. http://www.niehs. nih.gov/health/assets/docs a e/climatereport2010.pdf, Accessed 2011.
57. Macdonald RW, Mackay D, Li YF, Hickie B. How will global climate change affect risks from long-range transport of persistent organic pollutants? Hum Ecol Risk Assess. 2003;9(3):643-660. (Pubitemid 38571522)
58. Mpelasoka F, Hennessy K, Jones R, Bates B. Comparison of suitable drought indices for climate change impacts assessment over Australia towards resource management. Int J Climatol. 2008;28(10):1283-1292.
59. Lovreglio P, Barbieri A, Carrieri M, Sabatini L, Fracasso ME, Doria D, et al. Validity of new biomarkers of internal dose for use in the biological monitoring of occupational and environmental exposure to low concentrations of benzene and toluene. Int Arch Occup Environ Health. 2010;83(3):341-356.
60. Prins GS, Tang WY, Belmonte J, Ho SM. Perinatal exposure to oestradiol and bisphenol A alters the prostate epigenome and increases susceptibility to carcinogenesis. Basic Clin Pharmacol Toxicol. 2008;102(2):134-138. (Pubitemid 351143423)
61. Sarigiannis DA, Hansen U, Karakitsios SP. D3.2.1/2 Methodologies for quantifying health effects of exposure by multiple routes and the effects of mixtures in the light of the case studies, including a report on suitable indices of exposure. 2010. http://www.heimtsa.eu, Accessed 2011.
62. Dolinoy DC. The agouti mouse model: an epigenetic biosensor for nutritional and environmental alterations on the fetal epigenome. Nutr Rev. 2008;66 (Suppl 1):S7-11.
63. Rappaport SM. Implications of the exposome for exposure science. J Expo Sci Environ Epidemiol. 2011;21(1):5-9.
64. Adler T, Sawyer K, Shelton-Davenport M. The exposome: a powerful approach for evaluating environmental exposures and their influences on human disease. http://dels-old.nas.edu/envirohealth/newsletters/newsletter3 exposomes.pdf, Accessed 2011.
65. Centers for Disease Control and Prevention. Exposome and exposomics. http://www.cdc.gov/niosh/topics/exposome, Accessed 2011.
66. de Kok TM, Moonen HJ, van Delft J, van Schooten FJ. Methodologies for bulky DNA adduct analysis and biomonitoring of environmental and occupational exposures. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;778(1-2):345-355.
67. Airoldi L, Vineis P, Colombi A, Olgiati L, Dell'Osta C, Fanelli R, et al. 4-Aminobiphenyl-hemoglobin adducts and risk of smoking-related disease in never smokers and former smokers in the European Prospective Investigation into Cancer and Nutrition prospective study. Cancer Epidemiol Biomarkers Prev. 2005;14(9):2118-2124. (Pubitemid 41603255)
68. Vlaanderen J, Moore LE, Smith MT, Lan Q, Zhang L, Skibola CF, et al. Application of OMICS technologies in occupational and environmental health research; current status and projections. Occup Environ Med. 2010;67(2):136-143.
69. Andrew AS, Jewell DA, Mason RA, Whitfield ML, Moore JH, Karagas MR. Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a US population. Environ Health Perspect. 2008;116(4):524-531. (Pubitemid 351864314)
70. Fry RC, Navasumrit P, Valiathan C, Svensson JP, Hogan BJ, Luo M, et al. Activation of inflammation/NF-kappaB signaling in infants born to arsenic-exposed mothers. PLoS Genet. 2007;3(11):e207.
71. Benton MA, Rager JE, Smeester L, Fry RC. Comparative genomic analyses identify common molecular pathways modulated upon exposure to low doses of arsenic and cadmium. BMC Genomics. 2011;12:173.
72. Wright CM, Larsen JE, Hayward NK, Martins MU, Tan ME, Davidson MR, et al. ADAM28: a potential oncogene involved in asbestos-related lung adenocarcinomas. Genes Chromosomes Cancer. 2010;49(8):688-698.
73. Forrest MS, Lan Q, Hubbard AE, Zhang L, Vermeulen R, Zhao X, et al. Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers. Environ Health Perspect. 2005;113(6):801-807. (Pubitemid 40862197)
74. McHale CM, Zhang L, Lan Q, Vermeulen R, Li G, Hubbard AE, et al. Global gene expression profiling of a population exposed to a range of benzene levels. Environ Health Perspect. 2011;119(5):628-634.
75. Golovine K, Makhov P, Uzzo RG, Kutikov A, Kaplan DJ, Fox E, et al. Cadmium down-regulates expression of XIAP at the post-transcriptional level in prostate cancer cells through an NF-kappaB-independent, proteasome-mediated mechanism. Mol Cancer. 2010;9:183.
76. Chan AT, Ogino S, Fuchs CS. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med. 2007;356(21):2131-2142. (Pubitemid 47010839)
77. Krizkova S, Fabrik I, Adam V, Hrabeta J, Eckschlager T, Kizek R. Metallothionein - a promising tool for cancer diagnostics. Bratisl Lek Listy. 2009;110(2):93-97.
78. Fachin AL,Mello SS, Sandrin-Garcia P, Junta CM, Ghilardi-Netto T, Donadi EA, et al. Gene expression profiles in radiation workers occupationally exposed to ionizing radiation. J Radiat Res (Tokyo). 2009;50(1):61-71.
79. Marsit CJ, Karagas MR, Schned A, Kelsey KT. Carcinogen exposure and epigenetic silencing in bladder cancer. Ann N Y Acad Sci. 2006;1076:810-821. (Pubitemid 44955311)
80. Marsit CJ, Houseman EA, Christensen BC, Gagne L, Wrensch MR, Nelson HH, et al. Identification of methylated genes associated with aggressive bladder cancer. PLoS One. 2010;5(8):e12334.
81. Chanda S, Dasgupta UB, Guhamazumder D, Gupta M, Chaudhuri U, Lahiri S, et al. DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. Toxicol Sci. 2006;89(2):431-437. (Pubitemid 43126001)
82. Smeester L, Rager JE, Bailey KA, Guan X, Smith N, Garcia-Vargas G, et al. Epigenetic changes in individuals with arsenicosis. Chem Res Toxicol. 2011;24(2):165-167.
83. Bollati V, Baccarelli A, Hou L, Bonzini M, Fustinoni S, Cavallo D, et al. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res. 2007;67(3):876-880.
84. Hegedus CM, Skibola CF, Warner M, Skibola DR, Alexander D, Lim S, et al. Decreased urinary beta-defensin-1 expression as a biomarker of response to arsenic. Toxicol Sci. 2008;106(1):74-82.
85. Tooker BC, Newman LS, Bowler RP, Karjalainen A, Oksa P, Vainio H, et al. Proteomic detection of cancer in asbestosis patients using SELDI-TOF discovered serum protein biomarkers. Biomarkers. 2011;16(2):181-191.
86. Tooker BC, Bowler RP, Orcutt JM, Maier LA, Christensen HM, Newman LS. SELDI-TOF derived serum biomarkers failed to differentiate between patients with beryllium sensitisation and patients with chronic beryllium disease. Occup Environ Med. 2011 PMID:21278142.
87. Vermeulen R, Lan Q, Zhang L, Gunn L, McCarthy D, Woodbury RL, et al. Decreased levels of CXC-chemokines in serum of benzene-exposed workers identified by array-based proteomics. Proc Natl Acad Sci U S A. 2005;102(47):17041-17046. (Pubitemid 41692680)
88. Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD, et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet. 2010;42(11):978-984.
89. Hung RJ, Boffetta P, Brennan P, Malaveille C, Gelatti U, Placidi D, et al. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis. 2004;25(6):973-978. (Pubitemid 38886083)
90. Lin GF, Guo WC, Chen JG, Qin YQ, Golka K, Xiang CQ, et al. An association of UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism with bladder cancer in benzidine-exposed workers in China. Toxicol Sci. 2005;85(1):502-506. (Pubitemid 40614279)
91. Carreon T, LeMasters GK, Ruder AM, Schulte PA. The genetic and environmental factors involved in benzidine metabolism and bladder carcinogenesis in exposed workers. Front Biosci. 2006;11:2889-2902. (Pubitemid 43804591)
92. Carreon T, Ruder AM, Schulte PA, Hayes RB, Rothman N,WatersM, et al. NAT2 slow acetylation and bladder cancer in workers exposed to benzidine. Int J Cancer. 2006;118(1):161-168. (Pubitemid 41681593)
93. Breton CV, Zhou W, Kile ML, Houseman EA, Quamruzzaman Q, Rahman M, et al. Susceptibility to arsenic-induced skin lesions from polymorphisms in base excision repair genes. Carcinogenesis. 2007;28(7):1520-1525. (Pubitemid 47241801)
94. Applebaum KM, Karagas MR, Hunter DJ, Catalano PJ, Byler SH, Morris S, et al. Polymorphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New Hampshire. Environ Health Perspect. 2007;15(8):1231-1236. (Pubitemid 351802357)
95. McCarty KM, Chen YC, Quamruzzaman Q, Rahman M, Mahiuddin G, Hsueh YM, et al. Arsenic methylation, GSTT1, GSTM1, GSTP1 polymorphisms, and skin lesions. Environ Health Perspect. 2007;115(3):341-345. (Pubitemid 46554430)
96. Schlawicke Engstrom K, Broberg K, Concha G, Nermell B, Warholm M, Vahter M. Genetic polymorphisms influencing arsenic metabolism: evidence from Argentina. Environ Health Perspect. 2007;115(4):599-605. (Pubitemid 46585533)
97. Kukkonen MK, Hamalainen S, Kaleva S, Vehmas T, Huuskonen MS, Oksa P, et al. Genetic susceptibility to asbestos related fibrotic pleuropulmonary changes. Eur Respir J. 2010 DOI: 10.1183/09031936.00049810.
98. Dianzani I, Gibello L, Biava A, Giordano M, Bertolotti M, Betti M, et al. Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study. Mutat Res. 2006; 599(1-2):124-134. (Pubitemid 44041510)
99. Shen M, Lan Q, Zhang L, Chanock S, Li G, Vermeulen R, et al. Polymorphisms in genes involved in DNA double-strand break repair pathway and susceptibility to benzene-induced hematotoxicity. Carcinogenesis. 2006;27(10):2083-2089. (Pubitemid 44530583)
100. Lan Q, Zhang L, Shen M, Jo WJ, Vermeulen R, Li G, et al. Large-scale evaluation of candidate genes identifies associations between DNA repair and genomic maintenance and development of benzene hematotoxicity. Carcinogenesis. 2009;30(1):50-58.
101. Shen M, Zhang L, Lee KM, Vermeulen R, Hosgood HD, Li G, et al. Polymorphisms in genes involved in innate immunity and susceptibility to benzene-induced hematotoxicity. Exp Mol Med. 2011;43(6):374-378.
102. McCanlies EC, Kreiss K, Andrew M,Weston A. HLA-DPB1 and chronic beryllium disease: a HuGE review. Am J Epidemiol. 2003 Mar 1;157(5):388-398. (Pubitemid 36258594)
103. Christiani DC, Mehta AJ, Yu CL. Genetic susceptibility to occupational exposures. Occup Environ Med. 2008;65(6):430-436; quiz 6, 397. (Pubitemid 351775807)
104. Ewis AA, Kondo K, Dang F, Nakahori Y, Shinohara Y, Ishikawa M, et al. Surfactant protein B gene variations and susceptibility to lung cancer in chromate workers. Am J Ind Med. 2006;49(5):367-373.
105. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11(12):1513-1530. (Pubitemid 36020002)
106. Sadetzki S, Flint-Richter P, Starinsky S, Novikov I, Lerman Y, Goldman B, et al. Genotyping of patients with sporadic and radiation-associated meningiomas. Cancer Epidemiol Biomarkers Prev. 2005;14(4):969-676.
107. Shaik AP, Jamil K. A study on the ALAD gene polymorphisms associated with lead exposure. Toxicol Ind Health. 2008;24(7):501-506.
108. Shaik AP, Jamil K. Polymorphisms in MGP gene and their association with lead toxicity. Toxicol Mech Methods. 2009;19(3):209-213.
109. World Health Organization. Primary prevention of cancer through migration of environmental and occupational determinants. International conference on environmental and occupational determinants of cancer: interventions for primary prevention. 2011. http://www.who.int/phe/news/events/international conference/Background interventions.pdf, Accessed 2011.
110. Jomova K, Jenisova Z, Feszterova M, Baros S, Liska J, Hudecova D, et al. Arsenic: toxicity, oxidative stress and human disease. J Appl Toxicol. 2011;31(2):95-107.
111. Kristal AR, Lippman SM. Nutritional prevention of cancer: new directions for an increasingly complex challenge. J Natl Cancer Inst. 2009;101(6):363-365.
112. Lippman SM. Cancer prevention research. Letter from the Editor. Cancer Prev Res (Phila). 2009;2(1):1-2.
113. Lawrence Livermore National Laboratory. The cooking makes a difference. 1995. https://www.llnl.gov/str/FoodSection3.html, Accessed 2011.
114. UK Health Safety Executives. The burden of occupational cancer in Great Britain. http://www.hse.gov.uk/research/rrpdf/rr595main.pdf, Accessed 2011.